Baseline characteristics of study participants by sex
| Values available | Women | Men | |
| Number of participants | 15 737 | 8185 | 7552 |
| Personal | |||
| Age, years* | 15 737 | 49.0 (8.3) | 49.0 (8.3) |
| Years of education | 15 396 | 11.1 (2.5) | 11.2 (2.8) |
| Family history of CHD,* % | 15 737 | 31.8 | 25.5 |
| SIMD-socioeconomic score* | 15 737 | 28.6 (22.0) | 28.0 (21.9) |
| ASSIGN cardiovascular risk score | 13 444 | 9.5 (9.9) | 14.8 (10.6) |
| Smoking | |||
| Ciggarette smoker, % | 15 737 | 40.2 | 51.6 |
| Cigarettes equivalent,* cigs/day | 15 737 | 6.6 (9.6) | 9.1 (11.9) |
| Expired air CO, ppm | 15 257 | 9.0 (11.5) | 10.6 (12.5) |
| Thiocyanate, lmol/L | 13 738 | 58.4 (1.98) | 57.8 (1.99) |
| Cotinine, ng/mL | 10 984 | 103 (152) | 128 (171) |
| Physical measurements | |||
| Height, m | 15 729 | 1.60 (0.06) | 1.73 (0.07) |
| Weight, kg | 15 727 | 65.9 (12.6) | 77.9 (12.5) |
| Body mass index, kg/m2 | 15 725 | 25.8 (4.8) | 26.0 (3.7) |
| Waist circumference, cm | 4061 | 80.5 (12.2) | 92.2 (11.6) |
| Waist-to-hip ratio | 4061 | 0.79 (0.071) | 0.92 (0.078) |
| Systolic BP,* mm Hg | 15 729 | 130.5 (21.1) | 134.0 (19.4) |
| Diastolic BP, mm Hg | 15 729 | 79.6 (11.9) | 83.4 (12.0) |
| Pulse pressure, mm Hg | 15 729 | 50.8 (15.1) | 50.6 (14.1) |
| Pulse rate, bpm | 15 661 | 78.6 (12.3) | 76.5 (13.3) |
| Diabetes mellitus | |||
| Diabetes mellitus,* % | 15 737 | 1.4 | 1.6 |
| Glucose, mmol/L (non-fasting) | 12 837 | 4.92 (1.36) | 5.17 (1.54) |
| Insulin, IU/mL (non-fasting) | 12 281 | 8.52 (9.60) | 11.2 (13.2) |
| C-peptide, mg/mL | 12 365 | 2.14 (1.82) | 2.41 (1.92) |
| Lipids | |||
| Total cholesterol,* mmol/L | 14 172 | 6.40 (1.30) | 6.23 (1.16) |
| HDL-cholesterol,* mmol/L | 13 460 | 1.63 (0.43) | 1.35 (0.37) |
| Triglycerides, mmol/L | 14 158 | 1.41 (1.69) | 1.91 (1.77) |
| LDL-cholesterol, mmol/L | 10 833 | 2.75 (1.19) | 2.65 (1.27) |
| Apolipoprotein A, g/L | 12 867 | 1.64 (0.30) | 1.49 (0.26) |
| Apolipoprotein B, g/L | 12 866 | 1.13 (0.32) | 1.18 (0.30) |
| Lipoprotein (a), mg/dL | 12 773 | 11.81 (3.38) | 9.55 (3.89) |
| Inflammatory | |||
| C-reactive protein, mg/L | 12 847 | 1.27 (3.10) | 1.53 (2.99) |
| Fibrinogen, g/L | 13 101 | 2.86 (0.81) | 2.75 (0.80) |
| Homocysteine, lmol/L | 12 843 | 14.0 (5.7) | 16.0 (6.6) |
| Ferritin, lmol/L | 12 319 | 38.0 (2.97) | 103.0 (2.64) |
| Cardiac | |||
| hsTroponin I, pg/mL | 11 527 | 2.25 (3.80) | 3.76 (2.60) |
| NT-pro-BNP, pg/mL | 10 507 | 61.5 (2.45) | 31.7 (2.94) |
| Diet-related | |||
| 25-hydroxyvitamin D raw, nmol/L | 11 603 | 39.2 (19.7) | 44.3 (22.7) |
| 25-hydroxyvitamin D adjusted, nmol/L | 11 603 | 39.4 (17.9) | 44.0 (19.3) |
| Vitamin B12, pg/mL | 12 355 | 423 (191) | 425 (180) |
| γ-glutamyl transferase, units/L | 12 835 | 18.5 (1.79) | 31.4 (1.92) |
| Renal-related | |||
| Uric acid, mmol/L | 14 178 | 243 (62) | 320 (66) |
| Creatinine, mmol/L | 11 837 | 81.4 (11.0) | 95.9 (12.9) |
| Cystatin-C, mg/L | 12 868 | 0.716 (0.165) | 0.760 (0.143) |
Values are means (SD) for continuous variables and as percentages for categorical variables.
BP, blood pressure; CHD, coronary heart disease; CO, carbon monoxide; HDL, high-density lipoprotein; hsTroponin, High-sensitivity troponin I; LDL, low-density lipoprotein; NT-pro-BNP, N-terminal pro brain natriuretic peptide; SIMD, Scottish Index of Multiple Deprivation
*ASSIGN risk score factors